Human immunodeficiency virus type-1 (HIV-1) evades antibody-dependent phagocytosis.

scientific article published on 27 December 2017

Human immunodeficiency virus type-1 (HIV-1) evades antibody-dependent phagocytosis. is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1371/JOURNAL.PPAT.1006793
P932PMC publication ID5760106
P698PubMed publication ID29281723

P50authorJohannes S. GachQ55302516
Enrico GrattonQ62059124
Marcus P WongQ88764877
Kuan-Ting YuQ89741673
Brijesh SharmaQ89741674
Donald N ForthalQ89741676
P2093author name stringAndrea Gorlani
Veronika Chromikova
Margaux Bouzin
P2860cites workFluorescence correlation spectroscopy. I. Conceptual basis and theoryQ56656039
Thermodynamic Fluctuations in a Reacting System—Measurement by Fluorescence Correlation SpectroscopyQ21563722
Antibody-Dependent Enhancement of Dengue Virus Infection in Primary Human Macrophages; Balancing Higher Fusion against Antiviral ResponsesQ25708015
Electron tomography of HIV-1 infection in gut-associated lymphoid tissueQ27331060
ADCC develops over time during persistent infection with live-attenuated SIV and is associated with complete protection against SIV(mac)251 challengeQ27342615
Diverse specificity and effector function among human antibodies to HIV-1 envelope glycoprotein epitopes exposed by CD4 bindingQ27675486
Broad and potent neutralizing antibodies from an African donor reveal a new HIV-1 vaccine targetQ29547347
Immune-correlates analysis of an HIV-1 vaccine efficacy trialQ29617377
Distribution and three-dimensional structure of AIDS virus envelope spikesQ29617562
An improved method for differentiating cell-bound from internalized particles by imaging flow cytometryQ30299956
The shaving reaction: rituximab/CD20 complexes are removed from mantle cell lymphoma and chronic lymphocytic leukemia cells by THP-1 monocytesQ30439425
A robust, high-throughput assay to determine the phagocytic activity of clinical antibody samplesQ30498394
A human antibody to the CD4 binding site of gp120 capable of highly potent but sporadic cross clade neutralization of primary HIV-1.Q31132248
Broadly neutralizing human anti-HIV antibody 2G12 is effective in protection against mucosal SHIV challenge even at low serum neutralizing titersQ33444658
In-solution virus capture assay helps deconstruct heterogeneous antibody recognition of human immunodeficiency virus type 1Q33725718
Which Antibody Functions are Important for an HIV Vaccine?Q33772637
Interactions between natural killer cells and antibody Fc result in enhanced antibody neutralization of human immunodeficiency virus type 1.Q33781055
Anti-phospholipid human monoclonal antibodies inhibit CCR5-tropic HIV-1 and induce beta-chemokinesQ33794973
Nonneutralizing functional antibodies: a new "old" paradigm for HIV vaccinesQ34057711
Fluorescence correlation spectroscopy: past, present, futureQ34114385
Broadly neutralizing anti-HIV-1 antibodies require Fc effector functions for in vivo activityQ34204325
Balance of cellular and humoral immunity determines the level of protection by HIV vaccines in rhesus macaque models of HIV infectionQ35156935
Poorly neutralizing cross-reactive antibodies against the fusion loop of West Nile virus envelope protein protect in vivo via Fcgamma receptor and complement-dependent effector mechanismsQ35531167
Antibody-Mediated Internalization of Infectious HIV-1 Virions Differs among Antibody Isotypes and SubclassesQ36118373
Neutrophils play an essential role in cooperation with antibody in both protection against and recovery from pulmonary infection with influenza virus in miceQ36484074
Longitudinal imaging of HIV-1 spread in humanized mice with parallel 3D immunofluorescence and electron tomographyQ37682792
HIV-specific antibody immunity mediated through NK cells and monocytesQ38160066
Functions of AntibodiesQ38535713
Role of monocytes in mediating HIV-specific antibody-dependent cellular cytotoxicityQ39307084
The direction of plasma membrane exchange between lymphocytes and accessory cells by trogocytosis is influenced by the nature of the accessory cell.Q39749803
Intimate cell conjugate formation and exchange of membrane lipids precede apoptosis induction in target cells during antibody-dependent, granulocyte-mediated cytotoxicityQ40117864
Photoinduced crosslinking of membrane proteins by fluorescein isothiocyanateQ40208304
Functions of Antibodies.Q41741684
Activation of intrinsic immune responses and microglial phagocytosis in an ex vivo spinal cord slice culture model of West Nile virus infectionQ41809363
Alveolar macrophages are critical for broadly-reactive antibody-mediated protection against influenza A virus in miceQ41919718
Fluorescence correlation spectroscopy. II. An experimental realizationQ43853123
Evidence for phagocytosis of influenza virus-infected, apoptotic cells by neutrophils and macrophages in miceQ45407549
FcgammaRIIa genotype predicts progression of HIV infection.Q46017436
Fc receptor but not complement binding is important in antibody protection against HIV.Q46545827
Recombinant gp120 vaccine-induced antibodies inhibit clinical strains of HIV-1 in the presence of Fc receptor-bearing effector cells and correlate inversely with HIV infection rateQ46775963
P275copyright licenseCreative Commons Attribution 4.0 InternationalQ20007257
P6216copyright statuscopyrightedQ50423863
P433issue12
P921main subjectphagocytosisQ184726
P304page(s)e1006793
P577publication date2017-12-27
P1433published inPLOS PathogensQ283209
P1476titleHuman immunodeficiency virus type-1 (HIV-1) evades antibody-dependent phagocytosis
P478volume13

Reverse relations

cites work (P2860)
Q63246407Antibody-Dependent Cellular Phagocytosis in Antiviral Immune Responses
Q59352288Antibody-dependent cellular cytotoxicity in HIV infection
Q64263004Knowns and Unknowns of Assaying Antibody-Dependent Cell-Mediated Cytotoxicity Against HIV-1
Q91959282Moving the HIV vaccine field forward: concepts of protective immunity
Q62487341Rare Detection of Antiviral Functions of Polyclonal IgA Isolated from Plasma and Breast Milk Compartments in Women Chronically Infected with HIV-1
Q92478519V2-Specific Antibodies in HIV-1 Vaccine Research and Natural Infection: Controllers or Surrogate Markers
Q93150656Vaccine-induced V1V2-specific antibodies control and or protect against infection with HIV, SIV and SHIV

Search more.